The application of hyaluronic acid-containing artificial tears on the ocular surface of children receiving orthokeratology contact lens treatment

在接受角膜塑形镜治疗的儿童眼表应用含透明质酸的人工泪液

阅读:1

Abstract

Purpose: The purpose of this study was to compare the effects of the application of hyaluronic acid (HA)-containing artificial tears and non-HA artificial tears on the ocular surface of children receiving orthokeratology contact lens treatment. Method: Charts of patients fitted with orthokeratology contact lenses in any of 20 local clinics were reviewed in this retrospective cohort study. The patients were then categorized according to the artificial tear type used, resulting in 85 and 95 patients being placed into the non-HA and HA groups, respectively. The primary outcomes include fluorescein ocular surface staining and dry eye disease (DED)-related symptoms which were measured at 1, 3 and 6 months after orthokeratology contact lens treatment. An independent t test and Chi-square test were used for statistical analysis. Results: At one month, there was a statistically significant greater number of non-HA patients with staining (14 non-HA, 4 HA, P=0.017). In the final visit, the incidence of ocular surface stain was also significantly lower in the HA group (12 non-HA, 2 HA, P = 0.010). At one month, there was a statistically significant greater number of non-HA patients with DED-related symptoms (24 non-HA, 12 HA, P = 0.029). Finally, the number of DED-related symptoms was significantly lower in the HA group (P = 0.005). After a 6-month follow-up, the spherical equivalent refraction (SER) and axial length (AXL) values between the two groups showed no significant difference (all P > 0.05). Conclusions: The application of HA-containing artificial tears resulted in less ocular surface staining and fewer DED-related symptoms in children wearing overnight orthokeratology contact lenses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。